Abstract
Several new 2-substituted-4-aryl-6-phenylpyridazin-3(2H)-ones were synthesized and evaluated for in vivo anti-inflammatory and analgesic activities and possible in vitro COX-2 selectivity. To critically evaluate the possibility of deleterious effects of newly synthesized agents on normal hemostasis, anti-platelet activity and whole blood clotting time were also assessed. The structures of the synthesized compounds were confirmed on the basis of spectral data and elemental analysis. The present study has led to the identification of 4-(4-methoxyphenyl)-2-(2-(4-phenylpiperazin-1-yl)-2-oxoethyl)-6-phenylpyridazin-3(2H)-one (17) as an ideal anti-inflammatory agent with good affinity and remarkable selectivity for COX-2 enzyme without any ulcerogenic and cardiovascular side effects. In addition, at lower doses all the pyridazinone derivatives do not seem to affect normal hemostatic balance.
Similar content being viewed by others
References
Abouzid K, Bekhit SA (2008) Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity. Bioorg Med Chem 16:5547–5556
Banoglu E, Akoğlu C, Unlü S, Küpeli E, Yeşilada E, Sahin MF (2004) Amide derivatives of [6-(5-methyl-3-phenylpyrazole-1-yl)-3(2H)-pyridazinone-2-yl]acetic acids as potential analgesic and anti-inflammatory compounds. Arch Pharm (Weinheim) 337:7–14
Bansal R, Thota S (2013) Pyridazin-3 (2H)-ones: the versatile pharmacophore of medicinal significance. Med Chem Res 22(6):2539–2552
Cesari N, Biancalani C, Vergelli C, Dal Piaz V, Graziano A, Biagini P, Ghelardini C, Galeotti N, Giovannoni MP (2006) Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action. J Med Chem 49(26):7826–7835
Chan CC, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M (1995) Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharm Exp Ther 274:1531–1537
Chelucci RC, Dutra LA, Lopes Pires ME, de Melo TR, Bosquesi PL, Chung MC, Dos Santos JL (2014) Antiplatelet and antithrombotic activities of non-steroidal anti-inflammatory drugs containing an N-acyl hydrazone subunit. Molecules 19(2):2089–2099
Chintakunta VK, Akella V, Vedula MS, Mamnoor PK, Mishra P, Casturi SR, Vangoori A, Rajagopalan R (2002) 3-O-substituted benzyl pyridazinone derivatives as COX inhibitors. Eur J Med Chem 37:339–347
Coudert P, Couquelet J, Tronche P (1988) A new synthetic route to 4,6-diarylpyridazinones and some of their derivatives. J Heterocycl Chem 25:799–802. doi:10.1002/jhet.5570250318
Dannhardt G, Kiefer W (2001) Cyclooxygenase inhibitors-current status and future prospects. Eur J Med Chem 36:109–126
Dogruer DS, Sahin MF, Unlü S, Ito S (2000) Studies on some 3(2H)-pyridazinone derivatives with antinociceptive activity. Arch Pharm (Weinheim) 333:79–86
Dogruer DS, Kupeli E, Yesilada E, Sahin MF (2004) Synthesis of new 2-[1(2H)-phthalazinon-2-yl]acetamide and 3-[1(2H)-phthalazinon-2-yl]propanamide derivatives as antinociceptive and anti-inflammatory agents. Arch Pharm (Weinheim) 337:303–310
Ellis JE, Davis EM, Brower PL (1997) A novel and practical method for hydrocyanation of chalcones. Org Process Res Dev 1:250–252
Gu K, Bi L, Zhao M, Wang C, Ju J, Peng S (2007) Toward the development of chemoprevention agents. Part II: chemo-enzymatic synthesis and anti-inflammatory activities of a new class of 5-amino-2-substituted phenyl-1,3-dioxacycloalkanes. Bioorg Med Chem 15:6273–6290
MacKenzie RD, Blohm TR, Auxier EM, Henderson JG, Steinbach JM (1971) Effects of α-(p-(fluoren-9-ylidenemethyl)phenyl)-2-piperidineethanol (RMI 10,393) on Platelet Function. Exp Biol Med 137:662–667
Olsen AM, Fosbøl EL, Lindhardsen J, Folke F, Charlot M, Selmer C, BjerringOlesen J, Lamberts M, Ruwald MH, Køber L, Hansen PR, Torp-Pedersen C, Gislason GH (2012) Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study. Circulation 126(16):1955–1963
Ozkay UD, Ozkay Y, Can OD (2011) Synthesis and analgesic effects of 2-(2-carboxyphenyl-sulfanyl)-N-(4-substitutedphenyl)acetamide derivatives. Med Chem Res 2:152–157
Saeed MM, Khalil NA, Ahmed EM, Eissa KI (2012) Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone derivatives as non-ulcerogenic agents. Arch Pharm Res 35:2077–2092
Sahina MF, Badiçoglu B, Gökçe M, Küpeli E, Yeşilada E (2004) Synthesis and analgesic and antiinflammatory activity of methyl 6-substituted-3(2H)-pyridazinone-2-ylacetate derivatives. Arch Pharm (Weinheim) 337:445–452
Sotelo E, Ravina E (2000) Efficient aromatization of 4,5-dihydro-3(2H)-pyridazinones substituted at 5 position by using anhydrous copper (II) chloride. Synth Commun 30:1–7
Sotelo E, Fraiz N, Yáñez M, Terrades V, Laguna R, Cano E, Raviña E (2002) Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions. Bioorg Med Chem 10:2873–2882
Süküroglu M, CaliskanErgün B, Unlü S, Sahin MF, Küpeli E, Yesilada E, Banoglu E (2005) Synthesis, analgesic, and anti-inflammatory activities of [6-(3,5-dimethyl-4-chloropyrazole-1-yl)-3(2H)-pyridazinon-2-yl]acetamides. Arch Pharm Res 28:509–517
Sur TK, Biswas TK, Ali L, Mukherjee B (2003) Anti-inflammatory and anti-platelet aggregation activity of human placental extract. Acta Pharmacol Sin 24(2):187–192
Takaya M, Sato M, Terashima K, Tanizawa H, Maki Y (1979) A new nonsteroidal analgesic-antiinflammatory agent. Synthesis and activity of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone and related compounds. J Med Chem 22(1):53–58
Tanaka T, Ito S, Higashino R, Fukuta Y, Takei M, Kurimoto T, Tamaki H (1998) A new thromboxane receptor antagonist, Z-335, ameliorates experimental thrombosis without prolonging the rat tail bleeding time. Thromb Res 91:229–235
Unsal-Tan O, Ozden K, Rauk A, Balkan A (2010) Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones. Eur J Med Chem 45:2345–2352
Wang YY, Tang ZY, Dong M, Liu XY, Peng SQ (2004) Inhibition of platelet aggregation by polyaspartoyl l-arginine and its mechanism. Acta Pharmcol Sin 25:469–473
Acknowledgments
The authors are thankful to University Grants Commission, India, and Council of Scientific and Industrial Research, India, for providing financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sharma, D., Bansal, R. Synthesis of 2-substituted-4-aryl-6-phenylpyridazin-3(2H)-ones as potential anti-inflammatory and analgesic agents with cardioprotective and ulcerogenic sparing effects. Med Chem Res 25, 1574–1589 (2016). https://doi.org/10.1007/s00044-016-1588-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-016-1588-9